Skip to content

GILD

Gilead Sciences, Inc.

Operating cash flow, 2025
$10.0B
YoY, 2025
−7.5%
5-year CAGR
+4.2%
10-year CAGR
−7.2%

Operating cash flow

Operating cash flow by fiscal year

PeriodOperating cash flowYoY
2025$10.0B−7.5%
2024$10.8B+35.2%
2023$8.0B−11.8%
2022$9.1B−20.3%
2021$11.4B+39.4%
2020$8.2B−10.7%
2019$9.1B+8.9%
2018$8.4B−29.4%
2017$11.9B−30.2%
2016$17.0B−19.8%
2015$21.3B+65.8%
2014$12.8B+312.8%
2013$3.1B−2.8%
2012$3.2B−12.2%
2011$3.6B+28.4%
2010$2.8B−8.0%
2009$3.1B+43.7%
2008$2.1B+28.4%
2007$1.7B—